source
- Federal probe finds private Medicare Advantage plans deny rehab care, then reverse on appealA federal investigation has revealed that the nation's largest Medicare Advantage insurers routinely deny post-acute rehabilitative services to older and disabled beneficiaries. The review found t…
- J&J reports positive Phase 2/3 results for Imaavy in rare autoimmune anemia, paving way for label expansionJohnson & Johnson announced that its drug Imaavy, already approved for myasthenia gravis, produced durable hemoglobin improvements in a Phase 2/3 trial for warm autoimmune hemolytic anemia, a rare…